Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
described in the project overview. Owing to the current composition of the project team, there will be a mild preference for candidates opting for project 2 on “Models and machine learning”. An explanation
-
responses and recovery in humans. To this end we combine data from psychopharmacological experiments in healthy participants and real-world clinical data from surgery patients for a more in-depth
-
. Oppbevaringstiden regnes fra den siste gangen du var inne på nettsiden. Cookien slettes automatisk etter tidens utløp. Nedenfor kan du kan se en komplett liste over cookies. Slik avviser eller sletter du cookies Du
-
composition, herbivore resistance, and biofouling in S. latissima? The position will be available from 6th of January 2026. The application deadline is 13th of July 2025 Candidates must comply with Nord
-
, 9,000 employees and 43,000 students work to create knowledge for a better world. You will find more information about working at NTNU and the application process here. ... (Video unable to load from
-
nettsiden. Cookien slettes automatisk etter tidens utløp. Nedenfor kan du kan se en komplett liste over cookies. Slik avviser eller sletter du cookies Du kan til enhver tid avvis cookies på datamaskinen
-
only if sociotechnical systems are appropriately designed. “Command and Control” (C2) is the process taken by organisations and teams to achieve shared goals, and the C2 system is the underpinning
-
results with AI models and system simulations to create a digital twin of the PtX process for predictive optimization and scenario analysis. Funding This PhD position is generously funded through the Villum
-
such as calculating sample compositions, precise mixing using pipettes/scales, and handling instruments and equipment. You have a quantitative mindset with the ability to analyse data, make predictions, and
-
to study translational aspects of cancer (single-cell sequencing of immune cells, organoid co-cultures, cellular engineering via CRISPR/Cas9 technology, in vivo imaging, advanced animal models of allo-SCT